Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 5.13%2.46B | 7.07%2.41B | 7.50%2.23B | 11.19%8.92B | 11.04%2.26B | 13.26%2.34B | 11.24%2.25B | 9.06%2.07B | 11.23%8.02B | 8.90%2.04B |
| Operating revenue | 5.13%2.46B | 7.07%2.41B | 7.50%2.23B | 11.19%8.92B | 11.04%2.26B | 13.26%2.34B | 11.24%2.25B | 9.06%2.07B | 11.23%8.02B | 8.90%2.04B |
| Cost of revenue | 4.67%1.41B | 7.05%1.39B | 5.70%1.29B | 9.43%5.19B | 10.80%1.32B | 11.58%1.34B | 8.66%1.3B | 6.53%1.22B | 9.42%4.74B | 5.07%1.2B |
| Gross profit | 5.74%1.05B | 7.09%1.01B | 10.09%936.73M | 13.74%3.73B | 11.37%935.51M | 15.61%994.41M | 14.97%947.1M | 12.91%850.87M | 13.96%3.28B | 14.86%839.99M |
| Operating expense | 6.90%551.81M | 7.08%550.62M | 11.65%540.08M | 13.59%2.05B | 19.57%533.13M | 14.53%516.17M | 9.69%514.2M | 10.69%483.72M | 11.57%1.8B | 6.01%445.88M |
| Selling and administrative expenses | 6.27%236.48M | 6.17%242.97M | 13.32%250.13M | 10.55%883.45M | 9.64%211.34M | 13.35%222.53M | 5.76%228.85M | 13.98%220.74M | 14.74%799.12M | 8.43%192.75M |
| Depreciation amortization depletion | 7.39%315.33M | 7.82%307.66M | 10.25%289.95M | 16.00%1.16B | 27.13%321.79M | 15.44%293.64M | 13.07%285.35M | 8.07%262.98M | 9.17%1B | 4.24%253.12M |
| -Depreciation and amortization | 7.39%315.33M | 7.82%307.66M | 10.25%289.95M | 16.00%1.16B | 27.13%321.79M | 15.44%293.64M | 13.07%285.35M | 8.07%262.98M | 9.17%1B | 4.24%253.12M |
| Operating profit | 4.49%499.72M | 7.09%463.58M | 8.03%396.65M | 13.94%1.68B | 2.10%402.38M | 16.80%478.24M | 21.95%432.9M | 15.98%367.15M | 17.03%1.48B | 26.83%394.11M |
| Net non-operating interest income (expenses) | 1.04%-79.36M | -2.64%-80.44M | -3.49%-79.11M | -18.81%-315.2M | -19.24%-80.2M | -21.16%-80.19M | -18.37%-78.37M | -16.45%-76.44M | -35.09%-265.29M | -9.57%-67.26M |
| Non-operating interest income | 52.81%5.09M | -42.28%2.31M | -13.70%1.77M | 24.14%11.61M | -10.06%2.22M | 17.58%3.33M | 199.63%4.01M | -24.46%2.05M | 57.14%9.35M | -27.01%2.46M |
| Non-operating interest expense | 1.11%84.45M | 0.45%82.75M | 3.04%80.88M | 18.99%326.8M | 18.20%82.42M | 21.02%83.52M | 21.96%82.38M | 14.83%78.49M | 35.74%274.64M | 7.66%69.73M |
| Other net income (expenses) | -2,371.30%-45.59M | 313.18%6.02M | -109.83%-4.57M | -166.24%-602.54M | -264.94%-603.83M | 103.93%2.01M | 113.17%1.46M | -266.31%-2.18M | -1,401.16%-226.32M | -8,299.21%-165.46M |
| Special income (charges) | -1,975.49%-60.13M | 50.79%-4.03M | -1,719.21%-6.44M | -156.71%-613.01M | -254.71%-601.57M | 94.87%-2.9M | 24.58%-8.19M | 81.02%-354K | -1,209.91%-238.8M | -13,810.19%-169.6M |
| -Less:Write off | 1,975.49%60.13M | -50.79%4.03M | 1,719.21%6.44M | 156.71%613.01M | 254.71%601.57M | -94.87%2.9M | -24.58%8.19M | -81.02%354K | 1,209.91%238.8M | 13,810.19%169.6M |
| Other non-operating income (expenses) | 196.53%14.54M | 4.18%10.05M | 202.69%1.87M | -16.10%10.47M | -154.56%-2.26M | -8.71%4.9M | 4,923.50%9.65M | -157.44%-1.82M | 295.72%12.48M | 429.45%4.14M |
| Income before tax | -6.32%374.77M | 9.32%389.16M | 8.47%312.98M | -22.43%762.93M | -274.52%-281.65M | 36.93%400.06M | 28.18%355.98M | 14.40%288.54M | -6.24%983.5M | -35.79%161.39M |
| Income tax | -3.81%88.5M | 22.71%98.88M | 20.29%71.47M | -33.67%146.36M | -346.39%-85.65M | 46.11%92.01M | 17.55%80.58M | 9.24%59.41M | 3.62%220.68M | -39.08%34.76M |
| Earnings from equity interest net of tax | ||||||||||
| Net income | -7.07%286.27M | 5.40%290.28M | 5.40%241.51M | -19.17%616.57M | -254.79%-196M | 34.41%308.05M | 31.66%275.4M | 15.82%229.13M | -8.75%762.83M | -34.83%126.63M |
| Net income continuous operations | -7.07%286.27M | 5.40%290.28M | 5.40%241.51M | -19.17%616.57M | -254.79%-196M | 34.41%308.05M | 31.66%275.4M | 15.82%229.13M | -8.75%762.83M | -34.83%126.63M |
| Noncontrolling interests | 0 | 0 | 0 | -3,957.69%-1M | 0 | 0 | -102.63%-77K | -4,130.43%-927K | -92.33%26K | -143.14%-124K |
| Net income attributable to the company | -7.07%286.27M | 5.37%290.28M | 4.98%241.51M | -19.04%617.57M | -254.63%-196M | 34.50%308.05M | 31.68%275.48M | 16.30%230.05M | -8.72%762.8M | -34.78%126.75M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -7.07%286.27M | 5.37%290.28M | 4.98%241.51M | -19.04%617.57M | -254.63%-196M | 34.50%308.05M | 31.68%275.48M | 16.30%230.05M | -8.72%762.8M | -34.78%126.75M |
| Diluted earnings per share | -6.72%1.11 | 4.67%1.12 | 5.62%0.94 | -19.26%2.39 | -255.10%-0.76 | 33.71%1.19 | 32.10%1.07 | 15.58%0.89 | -8.92%2.96 | -35.53%0.49 |
| Basic earnings per share | -6.72%1.11 | 4.67%1.12 | 4.49%0.93 | -18.98%2.39 | -255.10%-0.76 | 33.71%1.19 | 32.10%1.07 | 15.58%0.89 | -8.95%2.95 | -34.67%0.49 |
| Dividend per share | 10.53%0.315 | 10.53%0.315 | 10.53%0.315 | 11.43%1.17 | 10.53%0.315 | 11.76%0.285 | 11.76%0.285 | 11.76%0.285 | 11.11%1.05 | 11.76%0.285 |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.